Namatame K, Sasaki E, Koh Y, Nakano H, Nakamura T, Shimada K, Iwai H, Suzuki K
Dept. of Surgery, Showa University Fujigaoka Hospital.
Gan To Kagaku Ryoho. 1991 Feb;18(2):259-64.
5-fluorouracil (5-FU) was orally administered before surgical operation to two groups of patients, one treated at 300 mg for 7 days and the other treated at 400 mg for 5 days, to examine the change of TSIR in gastric patients. Tumor tissue, lymph node and normal lesions were collected from removed specimens immediately frozen. As a result, there were no differences in FdUMP volumes of various tissues between 300 mg and 400 mg groups. TSIR tended to be higher in the order of normal tissue, lymph node and tumor lesions. TSIR was significantly higher in 400 mg group than 300 mg group. We believe that further studies on TSIR will provide a useful information as to various studies, including efficacy reinforcement by combination therapy, problems in resistance, histological efficacy and sensitivity tests.
对两组患者在手术前口服5-氟尿嘧啶(5-FU),一组以300毫克剂量服用7天,另一组以400毫克剂量服用5天,以检查胃癌患者的胸苷合成抑制率(TSIR)变化。从切除标本中立即采集肿瘤组织、淋巴结和正常组织并冷冻。结果,300毫克组和400毫克组各组织的氟脱氧尿苷一磷酸(FdUMP)量没有差异。TSIR按正常组织、淋巴结和肿瘤组织的顺序呈升高趋势。400毫克组的TSIR显著高于300毫克组。我们认为,对TSIR的进一步研究将为包括联合治疗增效、耐药问题、组织学疗效和敏感性测试在内的各种研究提供有用信息。